The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Mario Strazzabosco, Luca Fabris  Journal of Hepatology 
Immunotherapy of hepatocellular carcinoma
Hepatic CD141+IFNλ+ DC subset: One against all?
Notch signaling and new therapeutic options in liver disease
Pathological roles of purinergic signaling in the liver
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Mario Strazzabosco, Luca Fabris  Journal of Hepatology 
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 57, Issue 1, Pages 6-8 (July 2012)
Thrombocytopenia associated with chronic liver disease
Stem cell therapies for liver failure and cirrhosis
The gut microbiota and the liver
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
The origin of cancer stem cells
Mechanisms of Hepatic Fibrogenesis
Mesenchymal stromal cell therapy for liver diseases
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Volume 66, Issue 2, Pages (February 2017)
The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury  Veronika Lukacs-Kornek, Frank Lammert 
Marina Berenguer, Detlef Schuppan  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Targeting gut flora to prevent progression of hepatocellular carcinoma
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
Volume 45, Issue 4, Pages (October 2006)
Volume 41, Issue 5, Pages (November 2004)
Volume 59, Issue 3, Pages (September 2013)
Sinusoidal communication in liver fibrosis and regeneration
Emina Halilbasic, Thierry Claudel, Michael Trauner 
EASL Clinical Practice Guidelines: Wilson’s disease
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Marcel Klingenberg, Akiko Matsuda, Sven Diederichs, Tushar Patel 
Volume 63, Issue 2, Pages (August 2015)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Notch Signaling in Hepatocellular Carcinoma: Guilty in Association!
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Liver stem cells—prospects for clinical use
NASH animal models: Are we there yet?
Salvatore Papa, Concetta Bubici  Journal of Hepatology 
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Macrophage heterogeneity in liver injury and fibrosis
The dynamic biliary epithelia: Molecules, pathways, and disease
Volume 62, Issue 3, Pages (March 2015)
Autophagy in liver diseases: Time for translation?
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Volume 65, Issue 4, Pages (October 2016)
Statins: Old drugs as new therapy for liver diseases?
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Inflammatory pathways in alcoholic steatohepatitis
EpCAM in hepatocytes and their progenitors
Foxa1 and Foxa2 regulate bile duct development in mice
Genetics of hepatocellular carcinoma: The next generation
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Platelets arrive at the scene of fibrosis……studies
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Presentation transcript:

The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris  Journal of Hepatology  Volume 58, Issue 1, Pages 181-183 (January 2013) DOI: 10.1016/j.jhep.2012.08.006 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Epithelial–stromal interactions behave as critical regulators of liver repair mechanisms in response to biliary or hepatocellular damage. By alternatively activating Notch and Wnt signaling, the stroma microenvironment orchestrates the divergent specification of HPC towards the biliary or hepatocellular lineage, respectively. In biliary regeneration, the interaction of HPC with myofibroblasts expressing Jagged1 results in the activation of Notch2 in HPC, leading to their biliary specification (red left-sided section). In contrast, during hepatocellular regeneration, HPC are activated by Wnt3a released by macrophages in response to phagocytosis of debris from apoptotic hepatocytes. Wnt3a then stimulates the nuclear translocation of β-catenin, which promotes HPC differentiation towards the hepatocellular lineage (green right-sided section). In this bimodal crosstalk between HPC and adjacent inflammatory stromal cells, Numb plays a key role as “switcher”. HPC differentiation into mature cholangiocytes or hepatocytes leads to resolution. When these mechanisms fail, reactive cholangiocytes are activated in conjunction with persistent inflammation, mesenchymal cell activation, and portal fibrosis, ultimately leading to progression of liver disease (pathologic repair, center-sided section). Journal of Hepatology 2013 58, 181-183DOI: (10.1016/j.jhep.2012.08.006) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions